1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow 68 Ga-P16-093: new trials by email Literature Review of 68 Ga-P16-093 trials Research Report on 68 Ga-P16-093
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer Ga-68 P16-093 PET/CT scan - Prostate Cancer Recurrent, Prostate Cancer | Phase 1 / Phase 2 | Active not recruiting | Five Eleven Pharma, Inc. | 60 | 2018-05-10 | 2022-05-02 |
United States (1)
Mark Green, PhD (1)